NSGl 555/l NSG555l Examl 1–l (NEWl 2026/l
2027l Update)l Nursel Practitionersl inl
Primaryl Carel IIl Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Whatl isl thel primaryl characteristicl ofl inflammatoryl ocularl surfacel disease?
Answer:
Itl impactsl qualityl ofl lifel andl causesl tearl instability,l withl patientsl oftenl feelingl tired.
QUESTION
Whatl arel commonl causesl ofl inflammatoryl ocularl surfacel disease?
Answer:
Drugs,l contactl lensl use,l screenl time,l andl rheumatologicl conditions.
QUESTION
Whatl isl thel firstl linel treatmentl forl inflammatoryl ocularl surfacel disease?
Answer:
Artificiall tearsl orl ointments,l lifestylel changesl (smoking,l screenl time),l warml compresses,l
lidl hygiene,l andl anti-inflammatoryl medications.
QUESTION
Whatl isl thel prognosisl forl inflammatoryl ocularl surfacel disease?
,Answer:
Itl relapsesl andl isl chronic.
QUESTION
Whatl typel ofl hearingl lossl isl characterizedl byl graduallyl progressive,l predominantlyl high-
frequencyl loss?
Answer:
Age-relatedl hearingl loss.
QUESTION
Whatl isl thel mostl commonl forml ofl sensorineurall hearingl loss?
Answer:
Age-relatedl hearingl loss.
QUESTION
Howl isl conductivel hearingl lossl identifiedl usingl thel Weberl test?
Answer:
Thel soundl isl heardl louderl inl thel earl withl poorerl hearing.
QUESTION
Howl isl sensorineurall hearingl lossl identifiedl usingl thel Weberl test?
Answer:
Thel soundl radiatesl tol thel earl thatl hearsl better.
QUESTION
Whatl doesl thel Rinnel testl assessl inl hearingl loss?
Answer:
,Itl comparesl bonel conductionl (BC)l andl airl conductionl (AC)l ofl sound.
QUESTION
Whatl indicatesl conductivel hearingl lossl inl thel Rinnel test?
Answer:
Bonel conductionl (BC)l isl greaterl thanl airl conductionl (AC).
QUESTION
Whatl isl thel primaryl treatmentl forl age-relatedl hearingl loss?
Answer:
Hearingl amplificationl throughl contemporaryl hearingl aidsl orl cochlearl implants.
QUESTION
Whatl isl al keyl featurel ofl age-relatedl macularl degeneration?
Answer:
Deteriorationl ofl centrall vision,l whichl canl bel acutel orl chronic,l withl nol painl orl redness.
QUESTION
Whatl arel thel twol classificationsl ofl age-relatedl macularl degeneration?
Answer:
Dryl (atrophic,l geographic)l andl wetl (neovascular,l exudative).
QUESTION
Whatl isl thel mainl differencel betweenl dryl andl wetl age-relatedl macularl degeneration?
Answer:
Dryl isl graduall andl progressivel duel tol atrophy,l whilel wetl involvesl rapidl visionl lossl duel
tol choroidall newl vessell growth.
, QUESTION
Whatl arel commonl riskl factorsl forl age-relatedl macularl degeneration?
Answer:
Aging,l smoking,l genetics/familyl history,l andl lowl antioxidantl diet.
QUESTION
Whatl treatmentsl arel availablel forl dryl age-relatedl macularl degeneration?
Answer:
Pegcetacoplanl andl avacincaptadl pegol.
QUESTION
Whatl treatmentsl arel availablel forl wetl age-relatedl macularl degeneration?
Answer:
Inhibitorsl ofl vascularl endotheliall growthl factorsl suchl asl ranibizumab,l bevacizumab,l
aflibercept,l faricimab,l andl prolucizumab.
QUESTION
Whatl isl thel leadingl causel ofl irreversiblel centrall visionl lossl inl developingl countries?
Answer:
Age-relatedl macularl degeneration.
QUESTION
Whatl isl thel primaryl differencel betweenl cataractsl andl macularl degeneration?
Answer:
Cataractsl affectl thel lensl andl visionl lossl isl reversiblel withl surgery;l macularl degenerationl
affectsl centrall visionl andl isl notl reversible.
2027l Update)l Nursel Practitionersl inl
Primaryl Carel IIl Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Whatl isl thel primaryl characteristicl ofl inflammatoryl ocularl surfacel disease?
Answer:
Itl impactsl qualityl ofl lifel andl causesl tearl instability,l withl patientsl oftenl feelingl tired.
QUESTION
Whatl arel commonl causesl ofl inflammatoryl ocularl surfacel disease?
Answer:
Drugs,l contactl lensl use,l screenl time,l andl rheumatologicl conditions.
QUESTION
Whatl isl thel firstl linel treatmentl forl inflammatoryl ocularl surfacel disease?
Answer:
Artificiall tearsl orl ointments,l lifestylel changesl (smoking,l screenl time),l warml compresses,l
lidl hygiene,l andl anti-inflammatoryl medications.
QUESTION
Whatl isl thel prognosisl forl inflammatoryl ocularl surfacel disease?
,Answer:
Itl relapsesl andl isl chronic.
QUESTION
Whatl typel ofl hearingl lossl isl characterizedl byl graduallyl progressive,l predominantlyl high-
frequencyl loss?
Answer:
Age-relatedl hearingl loss.
QUESTION
Whatl isl thel mostl commonl forml ofl sensorineurall hearingl loss?
Answer:
Age-relatedl hearingl loss.
QUESTION
Howl isl conductivel hearingl lossl identifiedl usingl thel Weberl test?
Answer:
Thel soundl isl heardl louderl inl thel earl withl poorerl hearing.
QUESTION
Howl isl sensorineurall hearingl lossl identifiedl usingl thel Weberl test?
Answer:
Thel soundl radiatesl tol thel earl thatl hearsl better.
QUESTION
Whatl doesl thel Rinnel testl assessl inl hearingl loss?
Answer:
,Itl comparesl bonel conductionl (BC)l andl airl conductionl (AC)l ofl sound.
QUESTION
Whatl indicatesl conductivel hearingl lossl inl thel Rinnel test?
Answer:
Bonel conductionl (BC)l isl greaterl thanl airl conductionl (AC).
QUESTION
Whatl isl thel primaryl treatmentl forl age-relatedl hearingl loss?
Answer:
Hearingl amplificationl throughl contemporaryl hearingl aidsl orl cochlearl implants.
QUESTION
Whatl isl al keyl featurel ofl age-relatedl macularl degeneration?
Answer:
Deteriorationl ofl centrall vision,l whichl canl bel acutel orl chronic,l withl nol painl orl redness.
QUESTION
Whatl arel thel twol classificationsl ofl age-relatedl macularl degeneration?
Answer:
Dryl (atrophic,l geographic)l andl wetl (neovascular,l exudative).
QUESTION
Whatl isl thel mainl differencel betweenl dryl andl wetl age-relatedl macularl degeneration?
Answer:
Dryl isl graduall andl progressivel duel tol atrophy,l whilel wetl involvesl rapidl visionl lossl duel
tol choroidall newl vessell growth.
, QUESTION
Whatl arel commonl riskl factorsl forl age-relatedl macularl degeneration?
Answer:
Aging,l smoking,l genetics/familyl history,l andl lowl antioxidantl diet.
QUESTION
Whatl treatmentsl arel availablel forl dryl age-relatedl macularl degeneration?
Answer:
Pegcetacoplanl andl avacincaptadl pegol.
QUESTION
Whatl treatmentsl arel availablel forl wetl age-relatedl macularl degeneration?
Answer:
Inhibitorsl ofl vascularl endotheliall growthl factorsl suchl asl ranibizumab,l bevacizumab,l
aflibercept,l faricimab,l andl prolucizumab.
QUESTION
Whatl isl thel leadingl causel ofl irreversiblel centrall visionl lossl inl developingl countries?
Answer:
Age-relatedl macularl degeneration.
QUESTION
Whatl isl thel primaryl differencel betweenl cataractsl andl macularl degeneration?
Answer:
Cataractsl affectl thel lensl andl visionl lossl isl reversiblel withl surgery;l macularl degenerationl
affectsl centrall visionl andl isl notl reversible.
